E16.8
BillableOther specified disorders of pancreatic internal secretion
Other specified disorders of pancreatic internal secretion
Coding Notes
Inclusion Terms
Alternative clinical terms for this condition
- Increased secretion from endocrine pancreas of growth hormone-releasing hormone
- Increased secretion from endocrine pancreas of pancreatic polypeptide
- Increased secretion from endocrine pancreas of somatostatin
- Increased secretion from endocrine pancreas of vasoactive-intestinal polypeptide
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
Related Codes(7)
ICD-11 Equivalents(1)
ICD-11 Equivalents
View full mappingCorresponding ICD-11 codes from the WHO crosswalk mapping
Also Known As / Clinical Terms(101)
SNOMED CT
- Abnormality of glucagon secretion11178005
- Abnormality of secretion of glucagon11178005
- Excessive vasoactive intestinal peptide secretion39998009
- Pancreatic cholera39998009
- Verner-Morrison syndrome39998009
- WDHA syndrome39998009
- Werner Morrison syndrome39998009
- Abnormality of secretion of gastrin47344007
- Neonatal hypoglycaemia52767006
- Neonatal hypoglycemia52767006
- Abnormal hormone secretion53439008
- Disorder of hormone secretion53439008
- Depleted glucagon secretion61998001
- Glucagon deficiency61998001
- Hypoglucagonaemia61998001
- Hypoglucagonemia61998001
- Hypoinsulinism123762005
- Diminished gastrin secretion190444009
- Hypogastrinaemia190444009
- Hypogastrinemia190444009
- Abnormality of VIP - vasoactive intestinal peptide secretion237575002
- Abnormality of vasoactive intestinal peptide secretion237575002
- Abnormality of somatostatin secretion237577005
- Excessive somatostatin secretion237578000
- Hypersomatostatinaemia237578000
- Hypersomatostatinemia237578000
- Abnormality of PPP secretion237579008
- Abnormality of pancreatic polypeptide secretion237579008
- Excessive pancreatic polypeptide secretion237580006
- Abnormality of secretin secretion237581005
- Excessive secretin secretion237582003
- Abnormality of cholecystokinin-pancreozymin secretion237583008
- Excessive cholecystokinin-pancreozymin secretion237584002
- Abnormality of GIP secretion237585001
- Abnormality of gastric inhibitory peptide secretion237585001
- Excessive gastric inhibitory peptide secretion237586000
- Abnormality of enteroglucagon secretion237587009
- Abnormality of glicentin secretion237587009
- Excessive glicentin secretion237589007
- Abnormality of motilin secretion237590003
- Excessive motilin secretion237591004
- Abnormality of bombesin secretion237592006
- Excessive bombesin secretion237593001
- Non-diabetic disorder of endocrine pancreas302865004
- Hypoinsulinemic hypoglycaemia and body hemihypertrophy773666007
- Hypoinsulinemic hypoglycemia and body hemihypertrophy773666007
UMLS
- Increased secretion from endocrine pancreas of growth hormone-releasing hormoneC2874182
- Increased secretion from endocrine pancreas of pancreatic polypeptideC2874183
- Increased secretion from endocrine pancreas of somatostatinC2874184
- Increased secretion from endocrine pancreas of vasoactive-intestinal polypeptideC2874185
- Other specified disorders of pancreatic internal secretionC0154192
Clinical Terms
- Abnormality of somatostatin secretion
- Glucagon deficiency
- Excessive somatostatin secretion
- Abnormality of enteroglucagon secretion
- Abnormality of vasoactive intestinal peptide secretion
- Abnormality of GIP secretion
- Hypersomatostatinaemia
- Hypoglucagonaemia
- Abnormality of cholecystokinin-pancreozymin secretion
- Excessive cholecystokinin-pancreozymin secretion
- Excessive secretin secretion
- Neonatal hypoglycemia
- Increased secretion from endocrine pancreas of growth hormone-releasing hormone
- Hypogastrinemia
- Excessive bombesin secretion
- Hypoglucagonemia
- Abnormality of secretin secretion
- Excessive gastric inhibitory peptide secretion
- Excessive pancreatic polypeptide secretion
- Werner Morrison syndrome
- Abnormality of glicentin secretion
- Hypoinsulinemic hypoglycaemia and body hemihypertrophy
- Abnormality of pancreatic polypeptide secretion
- Increased secretion from endocrine pancreas of pancreatic polypeptide
- Abnormality of motilin secretion
- Hypoinsulinemic hypoglycemia and body hemihypertrophy
- Abnormality of gastric inhibitory peptide secretion
- Excessive vasoactive intestinal peptide secretion
- Hypersomatostatinemia
- Abnormality of secretion of glucagon
- WDHA syndrome
- Abnormality of PPP secretion
- Abnormality of bombesin secretion
- Non-diabetic disorder of endocrine pancreas
- Abnormality of secretion of gastrin
- Diminished gastrin secretion
- Abnormality of glucagon secretion
- Abnormal hormone secretion
- Excessive glicentin secretion
- Increased secretion from endocrine pancreas of somatostatin
- Pancreatic cholera
- Increased secretion from endocrine pancreas of vasoactive-intestinal polypeptide
- Excessive motilin secretion
- Neonatal hypoglycaemia
- Abnormality of VIP - vasoactive intestinal peptide secretion
- Disorder of hormone secretion
- Verner-Morrison syndrome
- Hypogastrinaemia
- Hypoinsulinism
- Depleted glucagon secretion
Frequently Asked Questions
What is the ICD-10 code for other specified disorders of pancreatic internal secretion?
The ICD-10-CM code for other specified disorders of pancreatic internal secretion is E16.8. The full clinical description is "Other specified disorders of pancreatic internal secretion". E16.8 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code E16.8 mean?
ICD-10-CM code E16.8 represents “Other specified disorders of pancreatic internal secretion”. It is classified under Chapter 4: Endocrine, Nutritional and Metabolic Diseases and is a billable/specific code that can be used on a claim.
Is E16.8 a billable code?
Yes, E16.8 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is E16.8 in?
E16.8 is in Chapter 4: Endocrine, Nutritional and Metabolic Diseases (codes E00-E89).
What codes cannot be used with E16.8?
E16.8 has Excludes1 notes indicating codes that cannot be used together with it, including: transitory endocrine and metabolic disorders specific to newborn (P70-P74).
What SNOMED CT codes does E16.8 map to?
E16.8 maps to 27 SNOMED CT concepts: 53439008, 237585001, 237579008, 237575002, 237592006, and 22 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for E16.8?
E16.8 is linked to 5 UMLS Concept Unique Identifiers: C2874182, C2874183, C2874184, C2874185, C0154192. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does E16.8 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like other specified disorders of pancreatic internal secretion affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of E16.8?
E16.8 maps to the ICD-11 code: 5A4Z (Disorders of glucose regulation or pancreatic internal secretion, unspecified).
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.